Blackstone puts $250M into Anagram to tackle cystic fibrosis complication

May 7, 2026 11:31 AM EDT FinancingStartups Black­stone puts $250M in­to Ana­gram to tack­le cys­tic fi­bro­sis com­pli­ca­tion Kyle LaHucik Biotech Correspondent Black­stone Life Sci­ences, fresh off one of the largest pri­vate in­vest­ment funds in in­dus­try his­to­ry, is putting $250 mil­lion to work on … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER